US Stock MarketDetailed Quotes

QNCX Quince Therapeutics

Watchlist
  • 1.760
  • +0.050+2.92%
Close Jan 15 16:00 ET
77.44MMarket Cap-1.42P/E (TTM)

About Quince Therapeutics Company

Quince Therapeutics, Inc.(formerly Cortexyme, Inc.) is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.

Company Profile

SymbolQNCX
Company NameQuince Therapeutics
Listing DateMay 9, 2019
Founded2012
CEOMr. Dirk Thye, M.D.
MarketNASDAQ
Employees32
Fiscal Year Ends12-31
Address611 Gateway Boulevard,Suite 273
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-910-5717

Company Executives

  • Name
  • Position
  • Salary
  • Dirk Thye, M.D.
  • Chief Executive Officer, Chief Medical Officer and Director
  • 1.33M
  • Brendan Hannah
  • Chief Operating Officer, Chief Compliance Officer, Chief Business Officer, Principal Financial Officer and Principal Accounting Officer
  • 847.50K
  • David A. Lamond
  • Chairman of the Board
  • 106.06K
  • Dr. Charles S. Ryan, J.D.,PhD
  • President
  • 817.56K
  • Rajiv Patni, M.D.
  • Director
  • --
  • Dr. Margaret A. McLoughlin, PhD
  • Independent Director
  • 82.06K
  • Christopher J. Senner
  • Independent Director
  • 87.56K
  • Dr. Luca Benatti, PhD
  • Independent Director
  • 52.80K
  • June Bray
  • Independent Director
  • 80.06K
  • Dr. Una S. Ryan,PhD
  • Lead Independent Director
  • 98.56K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.